VOTING
Your vote is Important!
Please be sure to vote your shares online now or vote by phone by dialing 866-834-5856.
Special Proxy Statement/Circular
View an enhanced version of our Special Proxy Statement/Circular.
View an enhanced version of our Special Proxy Statement/Circular.
You may request paper materials of the above annual materials online, by email or by calling 866-648-8133.
Please be sure to vote your shares online now or vote by phone by dialing 866-834-5856.
Fusion Pharmaceuticals is a clinical-stage biopharmaceutical company developing next-generation radiopharmaceuticals as precision medicines for the treatment of cancer. We have developed our Targeted Alpha Therapies, or TAT, platform together with our proprietary Fast-Clear™ linker technology to enable us to connect alpha particle emitting isotopes to antibodies and other targeting molecules in order to selectively deliver the therapies to tumors.